《2007AHMC澳大利亞靜脈免疫球蛋白臨床使用標(biāo)準(zhǔn)》內(nèi)容預(yù)覽

Disclaimer: Important information about this document
This document is not a substitute for medical advice obtained from an attending clinician in relation to a particular patient’s condition. The relevance and appropriateness of the information and recommendations in this document depend, amongst other things, on a correct diagnosis being made, the severity of the relevant condition being properly ascertained, and other relevant circumstances of the particular patient.
This document is designed to provide information to assist clinical decision making. The information and recommendations represent informed opinion based, where possible, upon systematic review of the evidence which was finalised by mid 2006. In the absence of published evidence, recommendations are based on clinical advice provided to the parties involved in developing this document (i.e. the Jurisdictional Blood Committee IVIg Working Party and its clinical advisers and consultants, the Jurisdictional Blood Committee, and the Commonwealth of Australia) up to June 2007.
This document deals only with the use of intravenous immunoglobulin and does not include any advice on other forms of treatment relevant to the conditions described.
Each of the parties involved in developing this document and each of their relevant employees expressly disclaims and accepts no responsibility for any consequences arising from relying upon the information or recommendations contained herein.

完整版下載《2007AHMC澳大利亞靜脈免疫球蛋白臨床使用標(biāo)準(zhǔn)》